Notably, several of these significantly deregulated proteins (CST3, CLU, GSN, CALM, and SERPINA3) have been previously studied as potential ALS markers in post-mortem spinal cord [70] or biofluids, such as CSF or plasma [9, 21, 51–54]. The gene discussed is CLU; the disease is amyotrophic lateral sclerosis.